|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Net product sales | |||||
| Royalty revenues | |||||
| Collaboration and license agreement revenues | |||||
| Total revenue | |||||
| Costs and expenses: | |||||
| Cost of sales | |||||
| Total cost of sales | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total costs and expenses | |||||
| (Loss) income from operations | |||||
| Investment and other income, net | |||||
| (Loss) income before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net (loss) income | |||||
| Other comprehensive income: | |||||
| Unrealized loss on securities available-for-sale, net of income tax provision of $0, $0, and $0, respectively | |||||
| Foreign currency translation gain, net of income tax provision of $0, $0, and $0, respectively | |||||
| Total other comprehensive income | |||||
| Comprehensive (loss) income | |||||
| Net (loss) income per share - basic (in dollars per share) | |||||
| Net (loss) income per share - diluted (in dollars per share) | |||||
| Shares used in computation of per share amounts - basic (in shares) | |||||
| Shares used in computation of per share amounts - diluted (in shares) | |||||
Loading...